Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 185

1.

Baseline gut microbiota predicts clinical response and colitis in metastatic melanoma patients treated with ipilimumab.

Chaput N, Lepage P, Coutzac C, Soularue E, Le Roux K, Monot C, Boselli L, Routier E, Cassard L, Collins M, Vaysse T, Marthey L, Eggermont A, Asvatourian V, Lanoy E, Mateus C, Robert C, Carbonnel F.

Ann Oncol. 2019 Aug 13. pii: mdz224. doi: 10.1093/annonc/mdz224. [Epub ahead of print] No abstract available.

PMID:
31408090
2.

The specification, acceptability and effectiveness of respite care and short breaks for young adults with complex healthcare needs: protocol for a mixed-methods systematic review.

Pilkington G, Knighting K, Bray L, Downing J, Jack BA, Maden M, Mateus C, Noyes J, O'Brien MR, Roe B, Tsang A, Spencer S.

BMJ Open. 2019 Jun 17;9(6):e030470. doi: 10.1136/bmjopen-2019-030470.

3.
4.

Post-shingles granulomatous dermatosis related to anti-programmed cell death 1.

Assi T, Danu A, Mateus C, Robert C, Michot JM, Ibrahim T, Lazarovici J, Ghez D, Rossignol J, Dartigues P, Terroir-Cassou-Mounat M, Ribrag V.

Immunotherapy. 2019 May;11(7):591-598. doi: 10.2217/imt-2018-0169.

PMID:
30943861
5.

The FAO/WHO International Food Safety Authorities Network in Review, 2004-2018: Learning from the Past and Looking to the Future.

Savelli CJ, Bradshaw A, Ben Embarek P, Mateus C.

Foodborne Pathog Dis. 2019 Jul;16(7):480-488. doi: 10.1089/fpd.2018.2582. Epub 2019 Mar 30.

6.

Neurotoxicity induced by targeted therapies in patients treated for metastatic melanoma.

Velter C, Libenciuc C, Routier E, Mateus C, Fahmy J, Ghoufi L, Lambotte O, Not A, Cauquil C, Claveau S, Claveau J, Robert C.

Eur J Cancer. 2019 Apr;111:8-11. doi: 10.1016/j.ejca.2019.01.017. Epub 2019 Feb 22. No abstract available.

PMID:
30798086
7.

Prevalence and Clinical Patterns of Ocular Complications Associated With Anti-PD-1/PD-L1 Anticancer Immunotherapy.

Bitton K, Michot JM, Barreau E, Lambotte O, Haigh O, Marabelle A, Voisin AL, Mateus C, Rémond AL, Couret C, Champiat S, Labetoulle M, Rousseau A.

Am J Ophthalmol. 2019 Jun;202:109-117. doi: 10.1016/j.ajo.2019.02.012. Epub 2019 Feb 15.

PMID:
30772350
8.

Renal toxicities associated with pembrolizumab.

Izzedine H, Mathian A, Champiat S, Picard C, Mateus C, Routier E, Varga A, Malka D, Leary A, Michels J, Michot JM, Marabelle A, Lambotte O, Amoura Z, Soria JC, Kaaki S, Quellard N, Goujon JM, Brocheriou I.

Clin Kidney J. 2019 Feb;12(1):81-88. doi: 10.1093/ckj/sfy100. Epub 2018 Nov 9.

9.

Haematological immune-related adverse events induced by anti-PD-1 or anti-PD-L1 immunotherapy: a descriptive observational study.

Delanoy N, Michot JM, Comont T, Kramkimel N, Lazarovici J, Dupont R, Champiat S, Chahine C, Robert C, Herbaux C, Besse B, Guillemin A, Mateus C, Pautier P, Saïag P, Madonna E, Maerevoet M, Bout JC, Leduc C, Biscay P, Quere G, Nardin C, Ebbo M, Albigès L, Marret G, Levrat V, Dujon C, Vargaftig J, Laghouati S, Croisille L, Voisin AL, Godeau B, Massard C, Ribrag V, Marabelle A, Michel M, Lambotte O.

Lancet Haematol. 2019 Jan;6(1):e48-e57. doi: 10.1016/S2352-3026(18)30175-3. Epub 2018 Dec 4.

PMID:
30528137
10.

Evolution and recurrence of gastrointestinal immune-related adverse events induced by immune checkpoint inhibitors.

de Malet A, Antoni G, Collins M, Soularue E, Marthey L, Vaysse T, Coutzac C, Chaput N, Mateus C, Robert C, Carbonnel F.

Eur J Cancer. 2019 Jan;106:106-114. doi: 10.1016/j.ejca.2018.10.006. Epub 2018 Nov 23.

PMID:
30476730
11.

Efficacy of Ketamine in the Treatment of Substance Use Disorders: A Systematic Review.

Jones JL, Mateus CF, Malcolm RJ, Brady KT, Back SE.

Front Psychiatry. 2018 Jul 24;9:277. doi: 10.3389/fpsyt.2018.00277. eCollection 2018. Review.

12.

Older melanoma patients aged 75 and above retain responsiveness to anti-PD1 therapy: results of a retrospective single-institution cohort study.

Ibrahim T, Mateus C, Baz M, Robert C.

Cancer Immunol Immunother. 2018 Oct;67(10):1571-1578. doi: 10.1007/s00262-018-2219-8. Epub 2018 Jul 28.

PMID:
30056599
13.

Drug-induced lupus erythematosus following immunotherapy with anti-programmed death-(ligand) 1.

Michot JM, Fusellier M, Champiat S, Velter C, Baldini C, Voisin AL, Danlos FX, Dakdouki YE, Annereau M, Mariette X, Robert C, Cherif K, Marabelle A, Mateus C, Lambotte O.

Ann Rheum Dis. 2019 Jul;78(7):e67. doi: 10.1136/annrheumdis-2018-213677. Epub 2018 Jun 1. No abstract available.

PMID:
29858173
14.

Sentinel lymph node biopsy in 33 non-melanoma skin cancers of the head and neck: A twelve-year experience with long-term follow-up.

Foy JP, Kolb F, Routier E, Cavalcanti A, Lumbroso J, Tomasic G, Mateus C, Temam S, Robert C, Moya-Plana A.

Clin Otolaryngol. 2018 Mar 24. doi: 10.1111/coa.13100. [Epub ahead of print] No abstract available.

PMID:
29575799
15.

Sentinel lymph node biopsy in cutaneous head and neck melanoma.

Evrard D, Routier E, Mateus C, Tomasic G, Lombroso J, Kolb F, Robert C, Moya-Plana A.

Eur Arch Otorhinolaryngol. 2018 May;275(5):1271-1279. doi: 10.1007/s00405-018-4934-3. Epub 2018 Mar 19.

PMID:
29552728
16.

Impact of long term care and mortality risk in community care and nursing homes populations.

Lopes H, Mateus C, Rosati N.

Arch Gerontol Geriatr. 2018 May - Jun;76:160-168. doi: 10.1016/j.archger.2018.02.009. Epub 2018 Feb 20.

PMID:
29524916
17.
18.

Characterization of liver injury induced by cancer immunotherapy using immune checkpoint inhibitors.

De Martin E, Michot JM, Papouin B, Champiat S, Mateus C, Lambotte O, Roche B, Antonini TM, Coilly A, Laghouati S, Robert C, Marabelle A, Guettier C, Samuel D.

J Hepatol. 2018 Jun;68(6):1181-1190. doi: 10.1016/j.jhep.2018.01.033. Epub 2018 Feb 8.

PMID:
29427729
19.

Ten Years after the Creation of the Portuguese National Network for Long-Term Care in 2006: Achievements and Challenges.

Lopes H, Mateus C, Hernández-Quevedo C.

Health Policy. 2018 Mar;122(3):210-216. doi: 10.1016/j.healthpol.2018.01.001. Epub 2018 Jan 11.

20.

Tolerance and outcomes of stereotactic radiosurgery combined with anti-programmed cell death-1 (pembrolizumab) for melanoma brain metastases.

Nardin C, Mateus C, Texier M, Lanoy E, Hibat-Allah S, Ammari S, Robert C, Dhermain F.

Melanoma Res. 2018 Apr;28(2):111-119. doi: 10.1097/CMR.0000000000000413.

PMID:
29356789
21.

Safety and efficacy of anti-programmed death 1 antibodies in patients with cancer and pre-existing autoimmune or inflammatory disease.

Danlos FX, Voisin AL, Dyevre V, Michot JM, Routier E, Taillade L, Champiat S, Aspeslagh S, Haroche J, Albiges L, Massard C, Girard N, Dalle S, Besse B, Laghouati S, Soria JC, Mateus C, Robert C, Lanoy E, Marabelle A, Lambotte O.

Eur J Cancer. 2018 Mar;91:21-29. doi: 10.1016/j.ejca.2017.12.008. Epub 2018 Jan 10.

PMID:
29331748
22.

Arterial thrombosis and anti-PD-1 blockade.

Boutros C, Scoazec JY, Mateus C, Routier E, Roy S, Robert C.

Eur J Cancer. 2018 Mar;91:164-166. doi: 10.1016/j.ejca.2017.11.018. Epub 2017 Dec 27. No abstract available.

PMID:
29289455
23.

IMPlementation of A Relatives' Toolkit (IMPART study): an iterative case study to identify key factors impacting on the implementation of a web-based supported self-management intervention for relatives of people with psychosis or bipolar experiences in a National Health Service: a study protocol.

Lobban F, Appleton V, Appelbe D, Barraclough J, Bowland J, Fisher NR, Foster S, Johnson S, Lewis E, Mateus C, Mezes B, Murray E, O'Hanlon P, Pinfold V, Rycroft-Malone J, Siddle R, Smith J, Sutton CJ, Walker A, Jones SH.

Implement Sci. 2017 Dec 28;12(1):152. doi: 10.1186/s13012-017-0687-4.

24.

Sarcoidosis post-anti-PD-1 therapy, mimicking relapse of metastatic melanoma in a patient undergoing complete remission.

Yatim N, Mateus C, Charles P.

Rev Med Interne. 2018 Feb;39(2):130-133. doi: 10.1016/j.revmed.2017.11.008. Epub 2017 Dec 23.

PMID:
29277453
25.

Infectious complications associated with the use of immune checkpoint inhibitors in oncology: reactivation of tuberculosis after anti PD-1 treatment.

Picchi H, Mateus C, Chouaid C, Besse B, Marabelle A, Michot JM, Champiat S, Voisin AL, Lambotte O.

Clin Microbiol Infect. 2018 Mar;24(3):216-218. doi: 10.1016/j.cmi.2017.12.003. Epub 2017 Dec 18. No abstract available.

26.

Significance of Immune-related Lipase Increase Induced by Antiprogrammed Death-1 or Death Ligand-1 Antibodies: A Brief Communication.

Michot JM, Ragou P, Carbonnel F, Champiat S, Voisin AL, Mateus C, Lambotte O, Annereau M.

J Immunother. 2018 Feb/Mar;41(2):84-85. doi: 10.1097/CJI.0000000000000202.

PMID:
29252914
27.

Fever reaction and haemophagocytic syndrome induced by immune checkpoint inhibitors.

Michot JM, Pruvost R, Mateus C, Champiat S, Voisin AL, Marabelle A, Lambotte O.

Ann Oncol. 2018 Feb 1;29(2):518-520. doi: 10.1093/annonc/mdx701. No abstract available.

PMID:
29088318
28.

Inflammatory gastrointestinal diseases associated with PD-1 blockade antibodies.

Collins M, Michot JM, Danlos FX, Mussini C, Soularue E, Mateus C, Loirat D, Buisson A, Rosa I, Lambotte O, Laghouati S, Chaput N, Coutzac C, Voisin AL, Soria JC, Marabelle A, Champiat S, Robert C, Carbonnel F.

Ann Oncol. 2017 Nov 1;28(11):2860-2865. doi: 10.1093/annonc/mdx403.

PMID:
29045560
29.

Colon Immune-Related Adverse Events: Anti-CTLA-4 and Anti-PD-1 Blockade Induce Distinct Immunopathological Entities.

Coutzac C, Adam J, Soularue E, Collins M, Racine A, Mussini C, Boselli L, Kamsukom N, Mateus C, Charrier M, Cassard L, Planchard D, Ribrag V, Fizazi K, Loriot Y, Lepage P, Scoazec JY, Robert C, Carbonnel F, Chaput N.

J Crohns Colitis. 2017 Oct 1;11(10):1238-1246. doi: 10.1093/ecco-jcc/jjx081.

PMID:
28967957
30.

Clinical outcomes after interstitial brachytherapy for early-stage nasal squamous cell carcinoma.

Bacorro W, Escande A, Temam S, Dumas I, Routier E, Gensse MC, Blanchard P, Janot F, Mateus C, Tao Y, Robert C, Deutsch E, Haie-Meder C, Chargari C.

Brachytherapy. 2017 Sep - Oct;16(5):1021-1027. doi: 10.1016/j.brachy.2017.06.009. Epub 2017 Jul 23.

PMID:
28743612
31.

Protocol for an online randomised controlled trial to evaluate the clinical and cost-effectiveness of a peer-supported self-management intervention for relatives of people with psychosis or bipolar disorder: Relatives Education And Coping Toolkit (REACT).

Lobban F, Robinson H, Appelbe D, Barraclough J, Bedson E, Collinge L, Dodd S, Flowers S, Honary M, Johnson S, Mateus C, Mezes B, Minns V, Murray E, Walker A, Williamson P, Wintermeyer C, Jones S.

BMJ Open. 2017 Jul 18;7(7):e016965. doi: 10.1136/bmjopen-2017-016965. Erratum in: BMJ Open. 2017 Sep 3;7(9):e016965corr1.

32.

Retrospective cohort study and biobanking of patients treated for hemangioma in childhood - telomeres as biomarker of aging and radiation exposure.

Frenzel M, Ricoul M, Benadjaoud MA, Bellamy M, Lenain A, Haddy N, Diallo I, Mateus C, de Vathaire F, Sabatier L.

Int J Radiat Biol. 2017 Oct;93(10):1040-1053. doi: 10.1080/09553002.2017.1337278. Epub 2017 Jun 26.

PMID:
28649877
33.

Prevalence of immune-related systemic adverse events in patients treated with anti-Programmed cell Death 1/anti-Programmed cell Death-Ligand 1 agents: A single-centre pharmacovigilance database analysis.

Le Burel S, Champiat S, Mateus C, Marabelle A, Michot JM, Robert C, Belkhir R, Soria JC, Laghouati S, Voisin AL, Fain O, Mékinian A, Coutte L, Szwebel TA, Dunogeant L, Lioger B, Luxembourger C, Mariette X, Lambotte O.

Eur J Cancer. 2017 Sep;82:34-44. doi: 10.1016/j.ejca.2017.05.032. Epub 2017 Jul 10.

PMID:
28646772
34.

Immune-related eosinophilia induced by anti-programmed death 1 or death-ligand 1 antibodies.

Bernard-Tessier A, Jeanville P, Champiat S, Lazarovici J, Voisin AL, Mateus C, Lambotte O, Annereau M, Michot JM.

Eur J Cancer. 2017 Aug;81:135-137. doi: 10.1016/j.ejca.2017.05.017. No abstract available.

PMID:
28624693
35.

Adverse drug events-Analysis of a decade. A Portuguese case-study, from 2004 to 2013 using hospital database.

Scripcaru G, Mateus C, Nunes C.

PLoS One. 2017 Jun 2;12(6):e0178626. doi: 10.1371/journal.pone.0178626. eCollection 2017.

36.

A decade of adverse drug events in Portuguese hospitals: space-time clustering and spatial variation in temporal trends.

Scripcaru G, Mateus C, Nunes C.

BMC Pharmacol Toxicol. 2017 May 10;18(1):34. doi: 10.1186/s40360-017-0140-y.

37.

Baseline gut microbiota predicts clinical response and colitis in metastatic melanoma patients treated with ipilimumab.

Chaput N, Lepage P, Coutzac C, Soularue E, Le Roux K, Monot C, Boselli L, Routier E, Cassard L, Collins M, Vaysse T, Marthey L, Eggermont A, Asvatourian V, Lanoy E, Mateus C, Robert C, Carbonnel F.

Ann Oncol. 2017 Jun 1;28(6):1368-1379. doi: 10.1093/annonc/mdx108.

PMID:
28368458
38.

Inflammatory bowel disease and cancer response due to anti-CTLA-4: is it in the flora?

Carbonnel F, Soularue E, Coutzac C, Chaput N, Mateus C, Lepage P, Robert C.

Semin Immunopathol. 2017 Apr;39(3):327-331. doi: 10.1007/s00281-016-0613-x. Epub 2017 Jan 16. Review.

PMID:
28093620
39.

Renal effects of immune checkpoint inhibitors.

Izzedine H, Mateus C, Boutros C, Robert C, Rouvier P, Amoura Z, Mathian A.

Nephrol Dial Transplant. 2017 Jun 1;32(6):936-942. doi: 10.1093/ndt/gfw382. Review.

PMID:
28025384
40.

Blue Lymphangitis of the Breast after Breast Cancer: Case Report.

Arfi A, Clavier A, Honart JF, Ammari S, Merabet Z, Mateus C, Arfi-Rouche J.

Breast J. 2017 May;23(3):348-351. doi: 10.1111/tbj.12738. Epub 2016 Dec 3.

PMID:
27914118
41.

A Novel Spectroscopically Determined Pharmacodynamic Biomarker for Skin Toxicity in Cancer Patients Treated with Targeted Agents.

Azan A, Caspers PJ, Bakker Schut TC, Roy S, Boutros C, Mateus C, Routier E, Besse B, Planchard D, Seck A, Kamsu Kom N, Tomasic G, Koljenović S, Noordhoek Hegt V, Texier M, Lanoy E, Eggermont AM, Paci A, Robert C, Puppels GJ, Mir LM.

Cancer Res. 2017 Jan 15;77(2):557-565. doi: 10.1158/0008-5472.CAN-16-1733. Epub 2016 Nov 11.

42.

Place des anti-PD1 dans la prise en charge des mélanomes cutanés.

Mateus C, Libenciuc C, Robert C.

Bull Cancer. 2016 Jun;103(6 Suppl 1):S4-S11. doi: 10.1016/S0007-4551(16)30140-0. Review. French.

PMID:
27494973
43.

Acute Lower Limb Ischaemia and Diabetes in a Patient Treated with Anti-PD1 Monoclonal Antibody for Metastatic Melanoma.

Thoreau B, Gouaillier-Vulcain F, Machet L, Mateus C, Robert C, Ferreira-Maldent N, Maillot F, Lioger B.

Acta Derm Venereol. 2017 Mar 10;97(3):408-409. doi: 10.2340/00015555-2504. No abstract available.

44.

Pattern of Retinal Nerve Fiber Layer Thickness Loss in Fetal Alcohol Syndrome: A Spectral-Domain Optical Coherence Tomography Analysis.

Menezes C, Ribeiro I, Coelho P, Mateus C, Teixeira C.

Acta Med Port. 2016 Apr;29(4):254-60. doi: 10.20344/amp.6871. Epub 2016 Apr 29.

45.

Cutaneous malignant melanoma in children and adolescents treated in pediatric oncology units.

Réguerre Y, Vittaz M, Orbach D, Robert C, Bodemer C, Mateus C, Plantaz D, Plouvier E, Lutz P, Rakotonjanahary J, Fraitag S, Martin L.

Pediatr Blood Cancer. 2016 Nov;63(11):1922-7. doi: 10.1002/pbc.26113. Epub 2016 Jun 27.

PMID:
27348579
46.

Safety profiles of anti-CTLA-4 and anti-PD-1 antibodies alone and in combination.

Boutros C, Tarhini A, Routier E, Lambotte O, Ladurie FL, Carbonnel F, Izzeddine H, Marabelle A, Champiat S, Berdelou A, Lanoy E, Texier M, Libenciuc C, Eggermont AM, Soria JC, Mateus C, Robert C.

Nat Rev Clin Oncol. 2016 Aug;13(8):473-86. doi: 10.1038/nrclinonc.2016.58. Epub 2016 May 4. Review.

PMID:
27141885
47.

Association of Pembrolizumab With Tumor Response and Survival Among Patients With Advanced Melanoma.

Ribas A, Hamid O, Daud A, Hodi FS, Wolchok JD, Kefford R, Joshua AM, Patnaik A, Hwu WJ, Weber JS, Gangadhar TC, Hersey P, Dronca R, Joseph RW, Zarour H, Chmielowski B, Lawrence DP, Algazi A, Rizvi NA, Hoffner B, Mateus C, Gergich K, Lindia JA, Giannotti M, Li XN, Ebbinghaus S, Kang SP, Robert C.

JAMA. 2016 Apr 19;315(15):1600-9. doi: 10.1001/jama.2016.4059. Erratum in: JAMA. 2016 Jun 14;315(22):2472.

PMID:
27092830
48.

Enhancing Legume Ecosystem Services through an Understanding of Plant-Pollinator Interplay.

Suso MJ, Bebeli PJ, Christmann S, Mateus C, Negri V, Pinheiro de Carvalho MA, Torricelli R, Veloso MM.

Front Plant Sci. 2016 Mar 18;7:333. doi: 10.3389/fpls.2016.00333. eCollection 2016. Review.

49.

Impact of dermatologic adverse events induced by targeted therapies on quality of life.

Charles C, Bungener C, Razavi D, Mateus C, Routier E, Lanoy E, Verschoore M, Robert C, Dauchy S.

Crit Rev Oncol Hematol. 2016 May;101:158-68. doi: 10.1016/j.critrevonc.2016.03.003. Epub 2016 Mar 5. Review.

PMID:
26995080
50.

Road traffic accidents and self-reported Portuguese car driver's attitudes, behaviors, and opinions: Are they related?

Bon de Sousa T, Santos C, Mateus C, Areal A, Trigoso J, Nunes C.

Traffic Inj Prev. 2016 Oct 2;17(7):705-11. doi: 10.1080/15389588.2016.1150591. Epub 2016 Feb 18.

PMID:
26889832

Supplemental Content

Loading ...
Support Center